Advancing Programs toward HBV-Cure and Microbiome Therapeutics
Our Microbiome Platform advancing oral biologic drug products
Our HBV-Cure Program advancing novel anti-virals towards cure
Assembly Biosciences, Inc. is a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome.
Thank you, your message has been sent.